Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment with vonoprazan for 3 weeks is not inferior to 8 weeks for the management of gastric ESD: a multicenter noninferiority randomized study.
Kato M, Hosoe N, Gotoda T, Kusano C, Kuramochi M, Yoshida H, Kimoto Y, Okamura Y, Imaeda H, Ito T, Miyamoto Y, Horii T, Mori H, Morohoshi Y, Ohno A, Kishino R, Kubosawa Y, Yoshimura K, Yahagi N, Kanai T. Kato M, et al. Among authors: morohoshi y. J Gastroenterol. 2023 Apr;58(4):358-366. doi: 10.1007/s00535-023-01966-z. Epub 2023 Feb 13. J Gastroenterol. 2023. PMID: 36781490 Clinical Trial.
Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.
Naganuma M, Sugimoto S, Mitsuyama K, Kobayashi T, Yoshimura N, Ohi H, Tanaka S, Andoh A, Ohmiya N, Saigusa K, Yamamoto T, Morohoshi Y, Ichikawa H, Matsuoka K, Hisamatsu T, Watanabe K, Mizuno S, Suda W, Hattori M, Fukuda S, Hirayama A, Abe T, Watanabe M, Hibi T, Suzuki Y, Kanai T; INDIGO Study Group. Naganuma M, et al. Among authors: morohoshi y. Gastroenterology. 2018 Mar;154(4):935-947. doi: 10.1053/j.gastro.2017.11.024. Epub 2017 Nov 22. Gastroenterology. 2018. PMID: 29174928 Clinical Trial.
Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study.
Naganuma M, Sugimoto S, Fukuda T, Mitsuyama K, Kobayashi T, Yoshimura N, Ohi H, Tanaka S, Andoh A, Ohmiya N, Saigusa K, Yamamoto T, Morohoshi Y, Ichikawa H, Matsuoka K, Hisamatsu T, Watanabe K, Mizuno S, Abe T, Suzuki Y, Kanai T; INDIGO Study Group. Naganuma M, et al. Among authors: morohoshi y. J Gastroenterol. 2020 Feb;55(2):169-180. doi: 10.1007/s00535-019-01625-2. Epub 2019 Sep 16. J Gastroenterol. 2020. PMID: 31529220 Clinical Trial.
Small-Bowel Lesions in Patients Taking Direct Oral Anticoagulants Detected Using Capsule Endoscopy.
Yamaoka M, Imaeda H, Hosoe N, Yoneno K, Kanno R, Mitsufuji T, Sasaki T, Akiyama Y, Ohgo H, Morohoshi Y, Kanai T, Yamamoto T, Mimura T, Ogata H, Araki N, Yamamoto K, Nakamoto H. Yamaoka M, et al. Among authors: morohoshi y. Gastroenterol Res Pract. 2020 Aug 11;2020:7125642. doi: 10.1155/2020/7125642. eCollection 2020. Gastroenterol Res Pract. 2020. PMID: 32849868 Free PMC article.
Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial.
Fukuda T, Aoki Y, Kiyohara H, Yokoyama A, Nakazawa A, Yoshimatsu Y, Sugimoto S, Nanki K, Mikami Y, Fukuhara K, Mizuno S, Sujino T, Mutaguchi M, Takabayashi K, Morohoshi Y, Hosoda Y, Ogata H, Iwao Y, Naganuma M, Kanai T. Fukuda T, et al. Among authors: morohoshi y. Inflamm Bowel Dis. 2024 Apr 24:izae088. doi: 10.1093/ibd/izae088. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38655866
37 results